Abstract:Importance: Generating robust and timely evidence about the respiratory health risks of electronic cigarettes (e-cigarettes) is critical for informing state and federal regulatory standards for product safety. Objective: To examine the association of e-cigarette use with incident respiratory conditions, including chronic obstructive pulmonary disease (COPD), emphysema, chronic bronchitis, and asthma. Design, setting, and participants: This prospective cohort study used data from the nationally representative cohort of US adults from the Population Assessment of Tobacco and Health (PATH) study, including wave 1 from 2013 to 2014, wave 2 from 2014 to 2015, wave 3 from 2015 to 2016, and wave 4 from 2016 to 2018. Individuals aged 18 years and older at baseline with no prevalent respiratory conditions were included in the analyses. Analyses were conducted from February to July 2020. Exposures: e-Cigarette use was assessed by self-reported current use status (never, former, or current) at baseline. Main outcomes and measures: Incident respiratory conditions, including COPD, emphysema, chronic bronchitis, and asthma, as well as a composite respiratory disease encompassing all 4 conditions. Results: Among 21 618 respondents included in the analyses, 11 017 (491%) were men and 12 969 (65.2%) were non-Hispanic White. A total of 14 213 respondents were never e-cigarette users, 5076 respondents (11.6%) were former e-cigarette users, and 2329 respondents (5.2%) were current e-cigarette users. Adjusted for cigarette and other combustible tobacco product use, demographic characteristics, and chronic health conditions, there was an increased risk of respiratory disease among former e-cigarette uses (incidence rate ratio [IRR], 1.28; 95% CI, 1.09-1.50) and current e-cigarette users (IRR, 1.31; 95% CI, 1.08-1.59). Among respondents with good self-rated health, the IRR for former e-cigarette users was 1.21 (95%CI, 1.00-1.46) and the IRR for current e-cigarette users was 1.43 (95% CI, 1.14-1.79). For specific respiratory diseases among current e-cigarette users, the IRR was 1.33 (95% CI, 1.06-1.67) for chronic bronchitis, 1.69 (95% CI, 1.15-2.49) for emphysema, 1.57 (95% CI, 1.15-2.13) for COPD, and 1.31 (95% CI, 1.01-1.71) for asthma. Conclusions and relevance: This cohort study found that e-cigarette use was associated with an increased risk of developing respiratory disease independent of cigarette smoking. These findings add important evidence on the risk profile of novel tobacco products.

The Chronic Nature of Smoking and Vaping: A Comprehensive Analysis

Oral and Systemic Health Implications of Electronic Cigarette Usage as Compared to Conventional Tobacco Cigarettes: A review of the literature

Effects of E-Cigarettes on the Lung and Systemic Metabolome in People with HIV

E-cigarettes and vaping, new spotlight on smoking as an old cardiovascular risk factor?

Altered Human Brain Anatomy in Chronic Smokers: a Review of Magnetic Resonance Imaging Studies

Nicotine e-cigarettes: considerations for healthcare providers

'Vaping is a break from all of that': Exploring attitudes, harm perceptions, cessation barriers and social dynamics among people who vape

Chronic E-Cigarette Use Impairs Endothelial Function on the Physiological and Cellular Levels

Current perspective on e-cigarette use and respiratory outcomes: mechanisms and messaging

E-Cigarette Use: Device Market, Study Design, and Emerging Evidence of Biological Consequences

Unveiling the Long-Term Lung Consequences of Smoking and Tobacco Consumption: A Narrative Review

Assessment of Respiratory Health Implications of Vaping: A Systematic Review of Toxicity Mechanisms and Adverse Effects of Electronic Nicotine Delivery Systems

Blood and urine multi-omics analysis of the impact of e-vaping, smoking, and cessation: from exposome to molecular responses

A Systematic Literature Review on the Composition, Health Impacts, and Regulatory Dynamics of Vaping

The Hidden Dangers: E-Cigarettes, Heated Tobacco, and Their Impact on Oxidative Stress and Atherosclerosis—A Systematic Review and Narrative Synthesis of the Evidence

Association of Electronic Cigarette Use With Incident Respiratory Conditions Among US Adults From 2013 to 2018

E-cigarettes, nicotine, the lung and the brain: multi-level cascading pathophysiology

The Untapped Biomarker Potential of MicroRNAs for Health Risk-Benefit Analysis of Vaping vs. Smoking

Health outcomes of electronic cigarettes

Understanding the Cardiovascular Fallout of E-cigarettes: A Comprehensive Review of the Literature

The Effects of Electronic Cigarette Use Patterns on Health-Related Symptom Burden and Quality of Life: Analysis of US Prospective Longitudinal Cohort Study Data